Jul. 14 at 5:39 PM
$PRE
Prenetics' IM8 Secures
$1 Billion Growth Financing from General Catalyst's Customer Value Fund (CVF)
Tuesday, 14th July at 1:35 pm
IM8 is the fastest-growing premium supplement brand ever recorded — over 50 million servings delivered to date, with approximately 200,000 servings currently delivered daily, and an order every 27 seconds
Prenetics raises full-year 2026 IM8 revenue guidance to
$210–220 million, up from
$190–210 million
IM8 expected to reach
$300 million in annualized run-rate revenue by year-end 2026
IM8 expected to deliver
$400 million or more in full-year 2027 revenue
Every
$1 invested in customer acquisition has returned
$1.44 in gross profit, blended across all mature cohorts